303
Views
28
CrossRef citations to date
0
Altmetric
Therapy

An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis

, , &
Pages 4-9 | Received 28 May 2008, Accepted 28 May 2008, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Luis J. Borda, Marina Perper & Jonette E. Keri. (2019) Treatment of seborrheic dermatitis: a comprehensive review. Journal of Dermatological Treatment 30:2, pages 158-169.
Read now
Gabriella Fabbrocini, Mariateresa Cantelli & Giuseppe Monfrecola. (2014) Topical nicotinamide for seborrheic dermatitis: an open randomized study. Journal of Dermatological Treatment 25:3, pages 241-245.
Read now
Charlene U Ang-Tiu, Chandra F Meghrajani & Clarita C Maano. (2012) Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials. Expert Review of Clinical Pharmacology 5:1, pages 91-97.
Read now
Semih Tatlican, Cemile Eren, Bilgen Oktay, Fatma Eskioglu & Pelin Kartal Durmazlar. (2010) Experience with repetitive use of pimecrolimus: Exploring the effective and safe use in the treatment of relapsing seborrheic dermatitis. Journal of Dermatological Treatment 21:2, pages 83-85.
Read now

Articles from other publishers (24)

Esther S. Kim & Connie Kang. (2023) Manage seborrhoeic dermatitis in older adults with customised regimens that address age-related factors. Drugs & Therapy Perspectives 39:7, pages 232-236.
Crossref
Somayeh Tajik, Fatemeh Sharifi, Behnaz Aflatoonian & Antonio Di Bartolomeo. (2023) A New Electrochemical Sensor for the Detection of Ketoconazole Using Carbon Paste Electrode Modified with Sheaf-like Ce-BTC MOF Nanostructure and Ionic Liquid. Nanomaterials 13:3, pages 523.
Crossref
Odeh Alsmeirat, Som Lakhani, Musab Egaimi, Osama Idris & Mohamed Elkhalifa. (2022) The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials. Cureus.
Crossref
Josiah Sowell, Sandra M. Pena & Boni E. Elewski. (2022) Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options. Drugs & Aging 39:5, pages 315-321.
Crossref
Ahmad Chehade & Jaggi Rao. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy 549 556.e5 .
Matthew Ladda, Vijay Sandhu, Arvin Ighani & Jensen Yeung. (2019) Off-label Uses of Topical Pimecrolimus. Journal of Cutaneous Medicine and Surgery 23:4, pages 442-448.
Crossref
G. Quéreux. (2019) Dermatitis seborreica. EMC - Dermatología 53:1, pages 1-9.
Crossref
Ayda Hatefi, Elaheh Rahimpour, Taravat Ghafourian, Fleming Martinez, Mohammad Barzegar-Jalali & Abolghasem Jouyban. (2019) Solubility of ketoconazole in N-methyl-2-pyrrolidone + water mixtures at T = (293.2 to 313.2) K. Journal of Molecular Liquids 281, pages 150-155.
Crossref
David E. Castillo, Ilana Gunczler, Katlein França & Jonette Keri. 2019. Advances in Integrative Dermatology. Advances in Integrative Dermatology 71 88 .
Juemin Zhao, Wenjia Sun, Chengfeng Zhang, Jiaqiang Wu, Yan Le, Chunyun Huang, Ye Liu & Leihong Xiang. (2018) Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis. Journal of Cosmetic Dermatology 17:1, pages 90-94.
Crossref
Aditya K. Gupta & Sarah G. Versteeg. (2016) Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review. American Journal of Clinical Dermatology 18:2, pages 193-213.
Crossref
Keli Wang, Yao Wu, Zhiyan Chi, Chang Shu, Lingjun Li, Jun Wei, Lei Tao, Pengcheng Ma & Li Ding. (2016) A highly sensitive LC–MS/MS method for determination of ketoconazole in human plasma: Application to a clinical study of the exposure to ketoconazole in patients after topical administration. Journal of Pharmaceutical and Biomedical Analysis 128, pages 504-509.
Crossref
Marina Jovanović & Zoran Golušin. (2016) Nonsteroidal Topical Immunomodulators in Allergology and Dermatology. BioMed Research International 2016, pages 1-11.
Crossref
Enembe O Okokon, Jos H Verbeek, Jani H Ruotsalainen, Olumuyiwa A Ojo & Victor Nyange Bakhoya. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Yee-Leng Teoh & Yong-Kwang Tay. 2015. Pediatric Skin of Color. Pediatric Skin of Color 289 294 .
Helena Kastarinen, Tuija Oksanen, Enembe O Okokon, Vesa V Kiviniemi, Kristiina Airola, Johanna Jyrkkä, Tuomas Oravilahti, Piia K Rannanheimo & Jos H Verbeek. (2014) Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp. Cochrane Database of Systematic Reviews 2017:8.
Crossref
S.H. Kwon, M.Y. Jeong, K.C. Park, S.W. Youn, C.H. Huh & J.I. Na. (2014) A new therapeutic option for facial seborrhoeic dermatitis: indole-3-acetic acid photodynamic therapy. Journal of the European Academy of Dermatology and Venereology 28:1, pages 94-99.
Crossref
Clio Dessinioti & Andreas Katsambas. (2013) Seborrheic dermatitis: Etiology, risk factors, and treatments:. Clinics in Dermatology 31:4, pages 343-351.
Crossref
Hamideh Azimi, Farideh Golforoushan, Mahnaz Jaberian, Shhla Talghini & Mohamad Goldust. (2013) Efficiency of terbinafine 1% cream in comparison with ketoconazole 2% cream and placebo in patients with facial seborrheic dermatitis. Journal of Dermatological Treatment, pages 1-3.
Crossref
Andrew N. Lin. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy 535 542.e4 .
R. Aschoff, W. Kempter & M. Meurer. (2011) Seborrhoisches EkzemSeborrheic Dermatitis. Der Hautarzt 62:4, pages 297-307.
Crossref
Dietrich AbeckDietrich Abeck. 2012. Häufige Hautkrankheiten in der Allgemeinmedizin. Häufige Hautkrankheiten in der Allgemeinmedizin 93 95 .
Andrew N. Lin. (2010) Innovative Use of Topical Calcineurin Inhibitors. Dermatologic Clinics 28:3, pages 535-545.
Crossref
Dietrich AbeckDietrich Abeck. 2010. Häufige Hautkrankheiten in der Allgemeinmedizin. Häufige Hautkrankheiten in der Allgemeinmedizin 91 93 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.